Bristol-Myers Squibb: Home
Australia, Hong Kong, India, Middle East, Singapore, South Africa, South Korea, Taiwan, Thailand Investigators

Bristol-Myers Squibb considers requests for clinical research trials from all clinical and therapeutic areas, and gives priority to proposals that support our medical plans in the following therapeutic areas: cardiovascular/metabolics, neuroscience, cancer, immunology and virology.

Australia, Hong Kong, South Korea, Taiwan, Thailand, Singapore, Middle East, India, and South Africa Investigators, click here.


The Bristol-Myers Squibb ISR application process provides a framework and allows investigators to work from a common set of criteria, requirements and schedule of events. The process is designed to ensure scientific rigor and patient safety while supporting unique research ideas and providing insights into areas of unmet medical need.

Bristol-Myers Squibb will be accepting research proposals/applications beginning April 15, 2013 through midnight June 30, 2013. It is imperative that your application is received on or before April 15, 2013, to ensure that it is considered during the established review cycle. An internal Scientific Research committee will be assessing all submitted applications with the intent of conveying the committee’s decision by August 1, 2013.


Requests for Research Proposals are not to be interpreted as suggesting that any product is safe or effective for an investigational use or recommended for any use outside of its approved labeling. Bristol-Myers Squibb does not guarantee support. Please note that studies may be submitted for “drug-only” support as well as drug & funding support. Support is solely recognized at the time of full execution of the clinical research agreement.

Please click here to agree and return to a saved application.

For all other countries, click here.

Click here for trademark information on Bristol-Myers Squibb products.


You are leaving to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.